It is noted that MALAT1 confers acquired malignant phenotypes of lung cancer cells [12, 13], as well as enhanced drug resistance for NSCLC cells by cooperation with microRNAs [14]. This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.